Skip to main content
placeholder image

Decreased 5‐HT2cR and GHSR1a interaction in antipsychotic drug‐induced obesity

Journal Article


Download full-text (Open Access)

Abstract


  • Second generation antipsychotics (SGAs), notably atypical antipsychotics includingolanzapine, clozapine and risperidone, can cause weight gain and obesity side ef-fects. Antagonism of serotonin 2c receptors (5-HT2cR) and activation of ghrelin re-ceptor type 1a (GHSR1a) signalling have been identified as a main cause of SGAinduced obesity. Here we review the pivotal regulatory role of the 5-HT2cR inghrelin-mediated appetite signalling. The 5-HT2cR dimerizes with GHSR1a to in-hibit orexigenic signalling, while 5-HT2cR antagonism reduces dimerization andincreases GHSR1a-induced food intake. Dimerization is specific to the unedited5-HT2cR isoform. 5-HT2cR antagonism by SGAs may disrupt the normal inhibi-tory tone on the GHSR1a, increasing orexigenic signalling. The 5-HT2cR and itsinteraction with the GHSR1a could serve as the basis for discovering novel ap-proaches to preventing and treating SGA-induced obesity.

Publication Date


  • 2018

Citation


  • Huang, X., Weston-Green, K. & Yu, Y. (2018). Decreased 5‐HT2cR and GHSR1a interaction in antipsychotic drug‐induced obesity. Obesity Reviews, 19 (3), 396-405.

Scopus Eid


  • 2-s2.0-85041717420

Ro Full-text Url


  • https://ro.uow.edu.au/cgi/viewcontent.cgi?article=2288&context=ihmri

Ro Metadata Url


  • http://ro.uow.edu.au/ihmri/1261

Number Of Pages


  • 9

Start Page


  • 396

End Page


  • 405

Volume


  • 19

Issue


  • 3

Place Of Publication


  • United Kingdom

Abstract


  • Second generation antipsychotics (SGAs), notably atypical antipsychotics includingolanzapine, clozapine and risperidone, can cause weight gain and obesity side ef-fects. Antagonism of serotonin 2c receptors (5-HT2cR) and activation of ghrelin re-ceptor type 1a (GHSR1a) signalling have been identified as a main cause of SGAinduced obesity. Here we review the pivotal regulatory role of the 5-HT2cR inghrelin-mediated appetite signalling. The 5-HT2cR dimerizes with GHSR1a to in-hibit orexigenic signalling, while 5-HT2cR antagonism reduces dimerization andincreases GHSR1a-induced food intake. Dimerization is specific to the unedited5-HT2cR isoform. 5-HT2cR antagonism by SGAs may disrupt the normal inhibi-tory tone on the GHSR1a, increasing orexigenic signalling. The 5-HT2cR and itsinteraction with the GHSR1a could serve as the basis for discovering novel ap-proaches to preventing and treating SGA-induced obesity.

Publication Date


  • 2018

Citation


  • Huang, X., Weston-Green, K. & Yu, Y. (2018). Decreased 5‐HT2cR and GHSR1a interaction in antipsychotic drug‐induced obesity. Obesity Reviews, 19 (3), 396-405.

Scopus Eid


  • 2-s2.0-85041717420

Ro Full-text Url


  • https://ro.uow.edu.au/cgi/viewcontent.cgi?article=2288&context=ihmri

Ro Metadata Url


  • http://ro.uow.edu.au/ihmri/1261

Number Of Pages


  • 9

Start Page


  • 396

End Page


  • 405

Volume


  • 19

Issue


  • 3

Place Of Publication


  • United Kingdom